Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Patent
1997-05-29
1999-11-30
Burke, Julie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
530300, 530350, 530395, 514 2, 514 8, 514 12, A61K 3900, C07K 1447, C12N 506
Patent
active
059938293
ABSTRACT:
There is disclosed a method of preparing a vaccine suitable for administration to humans for the prevention or treatment of cancer. The vaccine is prepared by culturing human cancer cells in a serum-free medium and recovering from the culture medium the cell surface antigens shed from the human cancer cells during culturing. After purification, the collected or recovered shed antigens are employed to produce a vaccine consisting essentially of said antigens for the treatment or prevention of human cancer.
REFERENCES:
patent: 5030621 (1991-07-01), Bystryn
patent: 5141742 (1992-08-01), Brown et al.
patent: 5192384 (1993-03-01), Bystryn
patent: 5635188 (1997-06-01), Bystryn et al.
Bystryn et al Journal of Biological Response Modifiers vol. 5 211-224, 1986.
Bystryn Recent Results in Cancer Research vol. 139 337-348, 1995.
Burke Julie
Katz, Esq. Robert D.
LandOfFree
Anti-cancer vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-cancer vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cancer vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1668283